M&A Deal Summary |
|
|---|---|
| Date | 2013-01-29 |
| Target | Catalana De Dispensación SA |
| Sector | Life Science |
| Buyer(s) | Advanced Accelerator Applications S.A. |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2002 |
| Sector | Life Science |
| Employees | 386 |
Advanced Accelerator Applications S.A. is a radiopharmaceutical company that develops, produces and commercializes Molecular Nuclear Medicines including Lutathera® (177Lu-DOTATATE), a first-in-class RLT product for neuroendocrine tumors (NETs). Radiopharmaceuticals, such as Lutathera, are unique medicinal formulations containing radioisotopes that are used clinically for both diagnosis and therapy. AAA was formed in 2002 and is based in Saint-Genis-Pouilly, France.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| Country: Spain M&A | 1 of 1 |
| Year: 2013 M&A | 1 of 1 |